| Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic A Sud, ME Jones, J Broggio, C Loveday, B Torr, A Garrett, DL Nicol, ... Annals of Oncology 31 (8), 1065-1074, 2020 | 613 | 2020 |
| Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study A Sud, B Torr, ME Jones, J Broggio, S Scott, C Loveday, A Garrett, ... The Lancet Oncology 21 (8), 1035-1044, 2020 | 515 | 2020 |
| Glioblastoma in England: 2007–2011 A Brodbelt, D Greenberg, T Winters, M Williams, S Vernon, VP Collins European Journal of Cancer 51 (4), 533-542, 2015 | 280 | 2015 |
| Federated learning enables big data for rare cancer boundary detection S Pati, U Baid, B Edwards, M Sheller, SH Wang, GA Reina, P Foley, ... Nature communications 13 (1), 7346, 2022 | 212 | 2022 |
| Aggregating evidence about the positive and negative effects of treatments M Williams, A Hunter Artificial Intelligence in Medicine 56 (3), 173 - 190, 2012 | 102* | 2012 |
| Machine learning and glioma imaging biomarkers TC Booth, M Williams, A Luis, J Cardoso, K Ashkan, H Shuaib Clinical radiology 75 (1), 20-32, 2020 | 93 | 2020 |
| Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study C Loveday, A Sud, ME Jones, J Broggio, S Scott, F Gronthound, B Torr, ... Gut 70 (6), 1053-1060, 2021 | 89 | 2021 |
| Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer V Patkar, C Hurt, R Steele, S Love, A Purushotham, M Williams, ... British Journal of Cancer 95 (11), 1490-1496, 2006 | 77 | 2006 |
| A phase I study of pegylated arginine deiminase (pegargiminase), cisplatin, and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma PE Hall, R Lewis, N Syed, R Shaffer, J Evanson, S Ellis, M Williams, ... Clinical Cancer Research 25 (9), 2708-2716, 2019 | 62 | 2019 |
| A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098 NF Brown, M Williams, HT Arkenau, RA Fleming, J Tolson, L Yan, J Zhang, ... Neuro-oncology 20 (12), 1634-1642, 2018 | 61 | 2018 |
| Harnessing ontologies for argument-based decision-making in breast cancer M Williams, A Hunter 19th IEEE International Conference on Tools with Artificial Intelligence …, 2007 | 56 | 2007 |
| Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin M Williams, A Swampillai, M Osborne, S Mawdsley, R Hughes, ... Cancer 119 (13), 2391-2398, 2013 | 53 | 2013 |
| Combining argumentation and Bayesian nets for breast cancer prognosis M Williams, J Williamson Journal of Logic, Language and Information 15, 155-178, 2006 | 49 | 2006 |
| Estimating progression-free survival in patients with glioblastoma using routinely collected data C Kelly, P Majewska, S Ioannidis, MH Raza, M Williams Journal of Neuro-oncology 135, 621-627, 2017 | 47 | 2017 |
| Assumption-based argumentation for decision-making with preferences: A medical case study X Fan, R Craven, R Singer, F Toni, M Williams Computational Logic in Multi-Agent Systems: 14th International Workshop …, 2013 | 45 | 2013 |
| The outcome of patients with surgically treated meningioma in England: 1999–2013. A cancer registry data analysis AR Brodbelt, ME Barclay, D Greenberg, M Williams, MD Jenkinson, ... British journal of neurosurgery 33 (6), 641-647, 2019 | 43 | 2019 |
| Surgeon volume and 30 day mortality for brain tumours in England PC Matt Williams, Peter Treasure, David Greenberg, Andrew Brodbelt British Journal of Cancer 115, 1379–1382, 2016 | 42 | 2016 |
| Fractionated Stereotactic Radiotherapy for Acoustic Neuromas: Long-term Outcomes CHC D.K. Woolfcorrespondenceemail, M. Williams, C.L. Goh, D.R. Henderson, R ... Clinical Oncology 25 (12), 734–738, 2013 | 35 | 2013 |
| A position statement on the utility of interval imaging in standard of care brain tumour management: defining the evidence gap and opportunities for future research TC Booth, G Thompson, H Bulbeck, F Boele, C Buckley, J Cardoso, ... Frontiers in oncology 11, 62, 2021 | 31 | 2021 |
| Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study S Kuku, M Williams, M McCormack International Journal of Gynecologic Cancer 23 (6), 2013 | 29 | 2013 |
Anthony HunterProfessor of Artificial Intelligence, University College LondonVerified email at cs.ucl.ac.uk
